Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

Go back to Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer
(NASDAQ: COLL) Delayed: 27.03 -0.51 (1.85%)
Previous Close $27.54    52 Week High $30.58 
Open $27.68    52 Week Low $8.24 
Day High $27.68    P/E N/A 
Day Low $27.01    EPS $0.00 
Volume 225,662